Continuing Education (CE)

Payers’ Perspectives ASH 2012 Update: Multiple Myeloma Treatment Trends and Strategies for Value-Based Care
Optimizing New and Emerging Therapies for Treatment and Symptom Management of Multiple Sclerosis in Managed Care
Evolving Role of Biologics: A Payer’s and Provider’s Perspective
ASH 2010 Update on Multiple Myeloma: Treatment Trends and Strategies for Value-Based Care
ASH 2010 Update on Non-Hodgkin Lymphoma: Alignment of the Current Treatment Landscape andValue-Based Care
Highlights from the American College of Cardiology 2010: An Update on Stroke for Payers and Pharmacists
Wellness and Prevention in Chronic Disease Consensus Statement
ASCO 2010 Highlights: An Update for Payers and Providers on Chronic Myelogenous Leukemia
Highlights from ASCO 2010: An Update on Breast Cancer for Payers and Pharmacists
Highlights from the American Academy of Neurology 2010: An Update for Payers and Pharmacists on Multiple Sclerosis
ASH Highlights on Idiopathic Thrombocytopenic Purpura: A Payer's and Pharmacist's Perspective
Payer Perspectives on Breast Cancer: Updates from the National Comprehensive Cancer Network 15th Annual Conference
Long-Term Care: Implications of Overactive Bladder and the Latest Treatment Options for Quality Care
ASH Highlights on Non-Hodgkin Lymphoma: A Payer's and Pharmacist's Perspective
Health System/Regional Variations in the Delivery of Care for Multiple Myeloma
Long-Term Care: Implications of Deep-Vein Thrombosis and the Latest Treatment Options for Quality Care
The 32nd Annual San Antonio Breast Cancer Symposium Highlights: A Payer’s and Pharmacist’s Perspective
Workplace Wellness and Disease Prevention: Focus on Obesity
Multiple Myeloma and Health Economics: Highlights from the 2009 ASH Annual Meeting
ASCO 2009 Highlights on Breast Cancer: A Payer’s and Pharmacist’s Perspective
NCCN Updated Guidelines for Breast Cancer: A Payer’s Perspective
Workplace Wellness and Disease Prevention: Focus on Stroke
Balancing Cost, Quality, and Access in Cancer Care
Balancing Cost, Quality, and Access in Chronic Myelogenous Leukemia Treatment
Pharmaceutical Research & Development in a Value-Based Healthcare System
Health Economics in the Treatment of Multiple Myeloma: Highlights from Recent Oncology Meetings
Cost, Quality, and Access Considerations in Colorectal Cancer Care
Breast Cancer, Multiple Myeloma, and Prostate Cancer
Specialty Pharmaceutical Utilization Strategies for Use of Biologic Response Modifiers
Recent Regulatory Changes in the Cough/Cold Market
The Promise of Evidence-Based Medicine for Clinical Decision-Making